These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT. Mitra S; Federico L; Zhao W; Dennison J; Sarkar TR; Zhang F; Takiar V; Cheng KW; Mani S; Lee JS; Mills GB Oncotarget; 2016 Jun; 7(26):40252-40265. PubMed ID: 27259233 [TBL] [Abstract][Full Text] [Related]
24. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin. Jeong BY; Cho KH; Jeong KJ; Park YY; Kim JM; Rha SY; Park CG; Mills GB; Cheong JH; Lee HY Exp Mol Med; 2018 Jan; 50(1):e435. PubMed ID: 29371698 [TBL] [Abstract][Full Text] [Related]
25. Knockdown of Ras-Related Protein 25 (Rab25) Inhibits the In Vitro Cytotoxicity and In Vivo Antitumor Activity of Human Glioblastoma Multiforme Cells. Ding B; Cui B; Gao M; Li Z; Xu C; Fan S; He W Oncol Res; 2017 Mar; 25(3):331-340. PubMed ID: 28281975 [TBL] [Abstract][Full Text] [Related]
26. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Tong M; Chan KW; Bao JY; Wong KY; Chen JN; Kwan PS; Tang KH; Fu L; Qin YR; Lok S; Guan XY; Ma S Cancer Res; 2012 Nov; 72(22):6024-35. PubMed ID: 22991305 [TBL] [Abstract][Full Text] [Related]
27. Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis. Bhat AA; Pope JL; Smith JJ; Ahmad R; Chen X; Washington MK; Beauchamp RD; Singh AB; Dhawan P Oncogene; 2015 Aug; 34(35):4570-80. PubMed ID: 25500541 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling. Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651 [TBL] [Abstract][Full Text] [Related]
29. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition. Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998 [TBL] [Abstract][Full Text] [Related]
30. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Cheng KW; Lahad JP; Kuo WL; Lapuk A; Yamada K; Auersperg N; Liu J; Smith-McCune K; Lu KH; Fishman D; Gray JW; Mills GB Nat Med; 2004 Nov; 10(11):1251-6. PubMed ID: 15502842 [TBL] [Abstract][Full Text] [Related]
31. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2. Sheng H; Shao J; O'Mahony CA; Lamps L; Albo D; Isakson PC; Berger DH; DuBois RN; Beauchamp RD Oncogene; 1999 Jan; 18(4):855-67. PubMed ID: 10023661 [TBL] [Abstract][Full Text] [Related]
32. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus. Jiang B; Zhang JS; Du J; Urrutia R; Barnard J Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230 [TBL] [Abstract][Full Text] [Related]
33. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25. Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309 [TBL] [Abstract][Full Text] [Related]
34. Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells. Yoo BH; Wu X; Li Y; Haniff M; Sasazuki T; Shirasawa S; Eskelinen EL; Rosen KV J Biol Chem; 2010 Feb; 285(8):5438-49. PubMed ID: 19778902 [TBL] [Abstract][Full Text] [Related]
35. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells. Pruitt K; Pestell RG; Der CJ J Biol Chem; 2000 Dec; 275(52):40916-24. PubMed ID: 11007784 [TBL] [Abstract][Full Text] [Related]
37. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133 [TBL] [Abstract][Full Text] [Related]
38. Malignant transformation of an epithelial cell by v-Src via tv-a-mediated retroviral infection: a new cell model for studying carcinogenesis. Fu SL; Huang YJ; Liang FP; Huang YF; Chuang CF; Wang SW; Yao JW Biochem Biophys Res Commun; 2005 Dec; 338(2):830-8. PubMed ID: 16256070 [TBL] [Abstract][Full Text] [Related]
39. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells. Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472 [TBL] [Abstract][Full Text] [Related]
40. mDia1 targets v-Src to the cell periphery and facilitates cell transformation, tumorigenesis, and invasion. Tanji M; Ishizaki T; Ebrahimi S; Tsuboguchi Y; Sukezane T; Akagi T; Frame MC; Hashimoto N; Miyamoto S; Narumiya S Mol Cell Biol; 2010 Oct; 30(19):4604-15. PubMed ID: 20679479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]